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Antigensa b s t r a c t
Vaccine development targeting protozoan parasites remains challenging, partly due to the complex inter-
actions between these eukaryotes and the host immune system. Reverse vaccinology is a promising
approach for direct screening of genome sequence assemblies for new vaccine candidate proteins.
Here, we applied this paradigm to Cystoisospora suis, an apicomplexan parasite that causes enteritis
and diarrhea in suckling piglets and economic losses in pig production worldwide. Using Next
Generation Sequencing we produced an 84 Mb sequence assembly for the C. suis genome, making it
the first available reference for the genus Cystoisospora. Then, we derived a manually curated annotation
of more than 11,000 protein-coding genes and applied the tool Vacceed to identify 1,168 vaccine candi-
dates by screening the predicted C. suis proteome. To refine the set of candidates, we looked at proteins
that are highly expressed in merozoites and specific to apicomplexans. The stringent set of candidates
included 220 proteins, among which were 152 proteins with unknown function, 17 surface antigens of
the SAG and SRS gene families, 12 proteins of the apicomplexan-specific secretory organelles including
AMA1, MIC6, MIC13, ROP6, ROP12, ROP27, ROP32 and three proteins related to cell adhesion. Finally,
we demonstrated in vitro the immunogenic potential of a C. suis-specific 42 kDa transmembrane protein,
which might constitute an attractive candidate for further testing.
 2017 The Author(s). Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Cystoisospora suis (syn. Isospora suis) is a protozoan parasite of
the phylum Apicomplexa (subclass Coccidia, order Eucoccidiorida,
family Sarcocystidae). This phylum contains almost exclusively
obligate endoparasites of animals, including species of great med-
ical and veterinary relevance such as Plasmodium falciparum and
Toxoplasma gondii. According to recent reevaluations of the coccid-
ian phylogeny (Ogedengbe et al., 2015; Samarasinghe et al., 2008),
the position of C. suis in the family Sarcocystidae constitutes an
outgroup of the cluster containing the genera Neospora, Hammon-
dia and Toxoplasma. The closest outgroup genus of C. suis in the
family Sarcocystidae is Sarcocystis, while the closest outgroup fam-
ily of Sarcocystidae is Eimeridae, which contains the genus Eimeria.Cystoisospora suis is responsible for neonatal porcine coccidiosis,
a diarrheal disease of suckling piglets that causes significant eco-
nomic losses in swine production worldwide (Lindsay et al.,
1992; Meyer et al., 1999; Mundt et al., 2005; Aliaga-Leyton et al.,
2011; Shrestha et al., 2015) (Torres, A., 2004. Prevalence survey
of Isospora suis in twelve European countries. Proceedings of the
18th IPVS Congress, Hamburg, Germany, p. 243). The disease is
commonly controlled with the triazinone toltrazuril, but drug costs
and pressure to reduce the use of drugs in livestock production are
increasing. Furthermore, resistance to toltrazuril has been
described among parasites of the genus Eimeria (Stephen et al.,
1997) and must be considered likely for C. suis. To date, no other
drugs have been shown to be effective if administered in a way
that is compatible with field use (Joachim and Mundt, 2011).
Alternative options for the control of this pathogen include vac-
cination. Immunological control measures (active or passive vacci-
nation) commonly provide longer lasting protection than
chemotherapeutic interventions and do not leave chemical resi-
dues in the host or the environment. Vaccine development for api-
complexan parasites has been hindered in part by their relatively
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screening. Moreover, many apicomplexans have proved capable
of evading immune killing by targeting immunoprivileged sites
or through extensive antigenic diversity (Stanisic et al., 2013). Vac-
cination against some apicomplexan parasites such as the Eimeria
spp. that infect chickens has been possible using formulations of
live unmodified or attenuated parasites, but vaccine production
requires passage and amplification in live animals with implica-
tions for cost, biosafety and animal welfare (Blake et al., 2015).
For other protozoan parasites, success has been harder to achieve.
However, progress towards antigen identification that could lead
to development of recombinant or vectored vaccines has improved
for several coccidian parasites in recent years (McAllister, 2014).
To date, no vaccine has been developed against C. suis although
previous studies have shown that cellular and humoral immune
responses are induced upon infection (Taylor, J., 1984. Immune
Response of Pigs to Isospora suis (Apicomplexa, Eimeriidae), PhD
Thesis, Auburn University, USA; Worliczek et al., 2010a; Schwarz
et al., 2013; Gabner et al., 2014) and that superinfection of sows
ante partum with high doses of oocysts can confer partial maternal
protection (Schwarz et al., 2014). Since the use of live, virulent vac-
cines in large amounts is not practical and attenuated lines are not
currently available for C. suis, a systematic search for proteins with
antigenic properties is required to find appropriate vaccine candi-
dates for testing and antigenic characterisation. A key step towards
the identification of appropriate antigens for many apicomplexans
has been the availability of genomic data, urging the development
of a C. suis genome sequence assembly.
The approach of finding vaccine candidates using a genome
sequence has been termed ‘‘reverse vaccinology”. This strategy
has become a powerful way to identify proteins that can elicit an
antigenic response with relevance to host/pathogen interaction.
Reverse vaccinology is based on in silico screening of protein
sequences to search for motifs and structural features responsible
for inducing an immune response. Examples include transmem-
brane domains, signal peptides for excretion or surface membrane
targeting and binding sites for Major Histocompatibility Complex
(MHC) proteins. While this method has been successfully applied
in bacterial pathogens (i.e. Pizza et al., 2000), only a few studies
have been performed on eukaryotic pathogens. Examples include
the apicomplexan species T. gondii (Goodswen et al., 2013,
2014b) and Neospora caninum (Goodswen et al., 2014a), as well
as helminths such as Schistosoma (de Oliveira Lopes et al., 2013).
Recently, the program Vacceed (Goodswen et al., 2014c) was
developed, providing a high-throughput pipeline specifically
designed to identify vaccine candidates in eukaryotic pathogens.
This program was tested on the coccidian T. gondii, where it
showed an accuracy of 97% in identifying proteins that corre-
sponded to previously validated vaccine candidates (Goodswen
et al., 2013).
In this work, we applied the reverse vaccinology paradigm to
identify potential vaccine candidates in C. suis. To accomplish this,
we used Illumina Next Generation Sequencing technology to
sequence the C. suis genome and annotate protein-coding genes
by combining ab initio and orthology predictions with gene models
derived from a C. suis merozoite RNA-Seq library. Additionally, the
annotation was manually curated at single gene resolution, greatly
enhancing the quality of the gene models. Vacceed was then
applied to perform a genome-wide screen for potential immuno-
genic proteins and identified 1,168 proteins with a high immuno-
genicity score. Finally, we validated the immunogenic potential of
a C. suis-specific 42 kDa transmembrane protein (CSUI_005805) by
performing an independent immunoblot analysis using positive
polyclonal sera from infected piglets. These results show how
reverse vaccinology, combined with comparative genomics and
transcriptomics, can be applied to a eukaryotic pathogen to guidethe identification of novel vaccine candidates as a starting point
to develop a vaccine against C. suis. Moreover, the C. suis genome
represents the first genomic sequence available for a member of
the Cystoisospora group and it might serve as a reference for future
studies involving Cystoisospora spp.
2. Materials and methods
2.1. Parasite material
For preparation of genomic DNA for sequencing, C. suis oocysts
(strain Wien I) were isolated from experimentally infected piglets,
left to sporulate in potassium bichromate and purified using a cae-
sium chloride gradient (Worliczek et al., 2010b). DNA was
extracted from 2.5  106 washed and pelleted sporulated oocysts
using a Peqlab Microspin tissue DNA kit (Peqlab, Erlangen, Ger-
many) following the manufacturer’s instructions. RNAse A diges-
tion was performed on the DNA before final purification.
Cystoisospora suis merozoites were maintained in IPEC-J2 cells as
described earlier (Worliczek et al., 2013). Free merozoites
(8  106) were harvested by collecting supernatant 6 days p.i.
and purified on a Percoll density gradient. Purified merozoites
were then filtered through Partec CellTrics disposable filters
(50 lm), washed twice with PBS and pelleted by centrifugation
at 1000g for 10 min. Total RNA was extracted from purified pel-
leted merozoites using a QIAamp RNA blood mini kit (Qiagen, Ger-
many) according to the manufacturer’s instructions and was
quantified using a spectrophotometer (NanoDrop 2000, Thermo
Fisher Scientific, USA).
2.2. Genome assembly
A total of 80 million paired-end 100 bp reads were generated
from an Illumina HiSeq 2000 platform (Source BioScience, UK)
(reads were deposited at the Short Reads Archive – accession num-
ber SRS1672208). A genome sequence was assembled into contigs
with CLC Genomics Workbench version 7.5 (CLC Bio-Qiagen, Aar-
hus, Denmark) using default parameters. In this study, we did
not attempt to assemble chromosomes, as the main interest was
in identifying proteins to screen for immunogenic features. To
remove possible contaminants, we aligned the contigs against
the non-redundant (nr) RefSeq protein database using BLASTN
(E < 105) with default parameters and removed all contigs with
a hit to non-apicomplexan organisms. Alignment of C. suis contigs
to N. caninum and T. gondii genomes was performed with PROmer
version 3.0.7 (Kurtz et al., 2004) (default parameters). Repetitive
content was computed using RepeatMasker version 4.0.5 (parame-
ters –species ‘‘toxoplasma apicomplexa”).
2.3. Genome annotation
Genes were annotated using Maker version 2.31.8 (Cantarel
et al., 2008), which is a pipeline that combines different annotation
tracks into a final set of gene models. Each annotation track was
produced using the following programs:
2.3.1. Augustus
Augustus is an ab initio gene predictor that can be trained with
an accurate set of gene models, if available. To construct the train-
ing set we started from the Cufflinks gene track (described in more
detail in Section 2.3.4), as it was based on the most accurate evi-
dence for transcription, namely RNA-Seq data. Transcript
sequences from the Cufflinks track were given to ORFPredictor ver-
sion 2.3 (Min et al., 2005) (parameters strand ‘+’) to predict the
location of each Coding Sequence (CDS). Transcripts were then fil-
N. Palmieri et al. / International Journal for Parasitology 47 (2017) 189–202 191tered according to the following criteria: (i) transcripts with
incomplete CDS were removed; (ii) in the case of multiple iso-
forms, the isoform with the longest CDS was retained; (iii) genes
without introns were removed; (iv) genes with at least one exon
made entirely of untranslated regions (UTRs) were removed; (v)
genes separated by at least 500 bp from the previous or next gene
were retained; (vi) genes with containing ambiguous nucleotides
(Ns) in the upstream or downstream 500 bp flanking regions were
removed. The resulting gene set was used to train Augustus version
3.01 (Stanke et al., 2006) to generate a new species model that was
provided as a species parameter for Augustus (default parameters)
to predict gene locations on the contigs and generate the final
track.2.3.2. Snap
Snap is an ab initio gene predictor. We used the same training
set constructed for Augustus to train Snap version 2006-07-28
(Korf, 2004) and generate the parameters file that was provided
to Snap (default parameters) together with the contigs to produce
the gene track.2.3.3. Exonerate
Exonerate is a homology based gene predictor which generates
gene models based on the assumption that gene sequence and
structure is conserved among closely related species. To create this
gene track, protein sequences from Eimeria tenella, N. caninum,
Hammondia hammondi and T. gondii were downloaded from Tox-
oDB (Gajria et al., 2008) release 24 and aligned to the contigs with
Exonerate version 2.2.0 (parameters -m protein2genome –soft-
masktarget –percent 20 –showtargetgff –bestn 1).2.3.4. Cufflinks
Cufflinks is an evidence-based gene predictor which constructs
gene models from RNA-Seq data. Total RNA was extracted from
merozoites harvested from an in vitro culture (Worliczek et al.,
2013) 6 days p.i. and sent for sequencing to GATC Biotech AG (Con-
stance, Germany) using an Illumina sequencer HiSeq 2500 to gen-
erate paired-end reads of 100 bp (reads were deposited at the
Short Reads Archive – accession number SRS1683974). A combined
reference including the pig and C. suis genome was created, as the
raw reads were likely to contain residual pig RNAs from the cell
culture from which the merozoites were extracted. The Sus scrofa
genome version 10.2 was downloaded from Ensembl (www.
ensembl.org) and concatenated to the C. suis contigs. Reads were
mapped to this combined reference with TopHat version 2.1.0
(Kim et al., 2013) (parameters –library-type fr-firststrand) (see
Supplementary Table S1 for RNA-Seq mapping statistics). Reads
mapped to the pig genome were filtered out and the resulting
BAM file was provided to Cufflinks version 2.2.1 (Trapnell et al.,
2010) (parameters –library-type fr-firststrand) to reconstruct gene
models. Cufflinks additionally computes the expression level of
each gene using the standard FPKM measure (Fragments per
Kilobase of Exon per Million reads mapped), which normalises
the number of reads mapped to a gene by gene length and the total
number of reads in the dataset (for more details see Mortazavi
et al. (2008)). Transcripts with low expression (FPKM < 1) were
removed and the output was converted to GFF3 format using the
cufflinks2gff3 script from the Maker pipeline. Additionally, junc-
tions derived from TopHat were converted to GFF3 with the
tophat2gff3 script from Maker and added to the Cufflinks GFF3 to
get the final track.
After generating the four gene tracks, Maker was run to gener-
ate the uncurated Maker track with the following parameters that
were provided in the configuration file:genome = FASTA with contigs
augustus_species = species name (cystoisospora) from the
Augustus training
snaphmm = HMM parameter file from the Snap training
protein = FASTA with proteins from E. tenella, N. caninum, H.
hammondi and T. gondii
Furthermore, these additional parameters were specified: (est2-
genome = 1, protein2genome = 1, pred_flank = 500, alt_s-
plice = 0, single_exon = 1, correct_est_fusion = 1).
2.4. Manual curation
The BAM file from TopHat, the four gene tracks (Augustus, Snap,
Exonerate, Cufflinks) and the uncurated Maker gene track were
loaded into the Integrative Genomics Viewer (IGV)
(Thorvaldsdottir et al., 2013). Each gene was independently
curated in the following way: in the case of incongruences among
tracks, priority was given to the Cufflinks evidence, followed by
Exonerate, Augustus and Snap. We decided to prioritise Augustus
over Snap, as Snap produced a high number of very short terminal
exons, which we cautiously regarded as unreliable. Gene models
corresponding to lowly expressed genes were resolved only in
some cases, as their exon–intron structure was often very frag-
mented. The genome and annotation of C. suis are available in
the National Center for Biotechnology Information, (NCBI, USA)
database under the accession number PRJNA341953.
2.5. Evaluation of annotation quality
To assess the quality of the annotation, cuffcompare (Trapnell
et al., 2010) was run to compute the fraction of final gene models
confirmed by each type of evidence (Cufflinks, Exonerate, Augus-
tus, Snap). To evaluate the completeness of the annotation, the core
eukaryotic proteins from Parra et al. (2007) were downloaded from
http://korflab.ucdavis.edu/datasets/cegma/core/core.fa and aligned
to the contigs with BLASTP (E < 105, query coverageP 30%),
retaining only the best hit. Eukaryotic core proteins that did not
align to contigs (unaligned proteins) were further analysed to
check for their presence in the RNA-Seq dataset using the following
steps: (i) RNA-Seq reads from merozoites were de novo assembled
into transcripts using Oases (Schulz et al., 2012) with default
parameters; (ii) unaligned proteins were aligned to the assembled
transcripts with TBLASTN (E < 105).
2.6. Functional annotation
Functional annotation was performed with Blast2GO (Conesa
et al., 2005) version 3.1.3 on the protein sequences using the fol-
lowing steps: (i) blastp-fast (E < 105) was run against the local
version of the nr database downloaded on 01 December, 2015
and used to generate a first version of the Gene Ontology (GO)
functional annotation; (ii) InterProScan (Jones et al., 2014) was
run and results were merged to the initial GO annotation in order
to extend it, (iii) ANNEX (Myhre et al., 2006) was run to further
augment the GO annotation. The final functional annotation also
allowed the identification of additional transposable elements that
were not found by RepeatMasker.
2.7. Detection of vaccine candidates
Initially, 403 protein sequences containing unknown amino
acids (‘X’) were filtered out. The software Vacceed (Goodswen
et al., 2014c) was used to identify potential immunogenic proteins.
Vacceed implements a machine learning approach that combines
independent sources of evidence for immunogenic features
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nalP (Petersen et al., 2011), TargetP (Emanuelsson et al., 2000),
Phobius (Kall et al., 2007), TMHMM (Sonnhammer et al., 1998),
MHC-I Binding and MHC-II Binding. The program finally assigns a
score between 0 and 1 to each protein to rank the protein from
low immunogenicity (score = 0) to high (score = 1). We excluded
MHC-II Binding in our analyses as data about MHC-II allele binding
affinity is unavailable for the pig. Moreover, prior to running Vac-
ceed the tool MHC-I Binding was trained using known immuno-
genic proteins as input. Since no known immunogenic proteins
were available for C. suis, we used T. gondii proteins from
Goodswen et al. (2014c) to train MHC-I Binding for affinity against
Swine Leukocyte Antigens (SLA) alleles, as T. gondii was the closest
relative for which a dataset of immunogenic and non-
immunogenic proteins was available. Moreover, as the computa-
tional burden of the MHC-I Binding predictor was very high, we
divided the Vacceed analysis into two steps: (i) we ran Vacceed
on all the protein sequences using each tool except MHC-I Binding
and ranked the proteins according to score; (ii) we selected all pro-
teins with a score > 0.75 and reran Vacceed on this subset using all
the tools, including MHC-I Binding. Finally, from the score distribu-
tion obtained after step ii, we selected as candidates only proteins
with a scoreP 0.998, corresponding to the top 25% of the score
distribution.2.8. Ortholog assignment for vaccine candidate genes
To assign orthologs of C. suis genes in the other coccidian spe-
cies, protein sequences from E. tenella, Sarcocystis neurona, N. can-
inum, H. hammondi and T. gondii were downloaded from ToxoDB
(Gajria et al., 2008) release 24 and clustered with the C. suis pro-
teins using the Orthology MAtrix (OMA) software (Altenhoff
et al., 2013) with parameters LengthTol = 0.30. For genes for which
OMA did not detect an ortholog in any species, we manually
screened for its presence in the ToxoDB database by looking at
the section ‘‘Orthologs and Paralogs within ToxoDB” within the
gene entry.2.9. Two-dimensional (2D) gel electrophoresis
For 2D gel electrophoresis, 6  106 merozoites harvested from
cell culture were purified and concentrated as described above
and directly dissolved in DIGE buffer (7 M urea, 2 M thiuourea,
4% CHAPS, 1% (w/v) DTT, 20 mM Tris) and centrifuged again at
20,000g for 10 min at 4 C. The protein concentration of each lysate
was determined by Bradford assay (Bradford, 1976). For separation
in the first dimension, an aliquot of 40 lg of protein was diluted in
300 ll of rehydration solution (8 M urea, 2% (w/v) CHAPS, 12.7 mM
DTT, 2% immobilised pH gradient (IPG) buffer, 0.002% (w/v) bro-
mophenol blue) and used to rehydrate 13 cm IPG strips with a
non-linear gradient pH 3–10 (Immobiline, GE Healthcare Life
Sciences, Uppsala, Sweden) for 18 h at room temperature. Isoelec-
tric focusing (IEF) was carried out (300 V ascending to 3,500 V for
90 min, followed by 3,500 V for 18 h) using a Multiphor II elec-
trophoresis chamber (GE Healthcare Life Sciences). After IEF, the
IPG strips were equilibrated with 10 mg/ml of DTT in equilibration
buffer (6 M urea, 30% glycerol, 2% (w/v) SDS, 0.002% (w/v) bro-
mophenol blue, 1.5 M Tris–HCl) for 20 min and further incubated
in the same buffer for another 20 min, replacing DTT with 25 mg/
ml of iodoacetamide. The IPG strips were then washed with deio-
nised water. In the second dimension, SDS–PAGE was performed
using vertical slab gels (1.5 mm; T = 12%, C = 2.6%, 1.5 M Tris–HCl,
10% SDS) under reducing conditions at 15 mA for 15 min, followed
by 25 mA in a Protean II electrophoresis chamber (Bio-RadLaboratories, Hercules, USA). Each gel was stained with silver
(Blum and Gross, 1987) and scanned using the program
ImageMasterTM 2D platinum v.7.0.2.10. Immunoblot analysis
Proteins separated by 2D gel electrophoresis were transferred
onto a Trans-Blot (Bio-Rad) nitrocellulose (NC) membrane
(0.45 lm) for 150 min at 35 V, 150 mA and 6W on a Nova Blot
semi-dry transfer system (Pharmacia Biotech, USA). The mem-
branes were dried overnight in the dark at room temperature.
The next day, blots were blocked for 1 h using 2% (w/v) BSA. After
three washes with TTBS buffer (100 mM Tris, 0.9% NaCl, 0.1%
Tween 20), the blots were incubated with porcine anti-C. suis
serum (Schwarz et al., 2013) (having an IFAT antibody
titerP 10,000) diluted in TTBS buffer (1:300) under gentle agita-
tion at room temperature for 30 min. After rinsing in TTBS for
15 min, blots were exposed to biotinylated goat anti-pig IgG (Vec-
tor laboratories, USA; 1:500 dilution) as secondary antibody for
30 min at room temperature, incubated with ABC solution (Vector
Laboratories) and finally detected by 3,30-5,50-tetramethylbenzi
dine (TMB). Pre-colostral sera from non-infected piglets served as
negative controls (Schwarz et al., 2013).2.11. Mass spectrometry
The spot of interest from 2D gel was excised, washed, destained
(Gharahdaghi et al., 1999), reduced with DTT and alkylated with
iodoacetamide (Jimenez et al., 2001). In-gel digestion was per-
formed with trypsin (Trypsin Gold, Mass Spectrometry Grade, Pro-
mega, Fitchburg, USA) according to Shevchenko et al. (1996) with a
final trypsin concentration of 20 ng/ll in 50 mM aqueous ammo-
nium bicarbonate and 5 mM calcium chloride. Dried peptides were
reconstituted in 10 ll of 0.1% (v/v) trifluoroacetic acid (TFA). Nano-
HPLC separation was performed on an Ultimate 3000 RSLC system
(Dionex, Amsterdam, Netherlands). Sample pre-concentration and
desalting were accomplished with a 5 mm Acclaim PepMap l-
precolumn (300 lm inner diameter, 5 lm particle size, and 100 Å
pore size) (Dionex) with a flow rate of 5 ll/min using a loading
solution (2% Acetonitrile (ACN) in 0.05% aqueous TFA). The separa-
tion was performed on a 25 cm Acclaim PepMap C18 column
(75 lm inner diameter, 3 lm particle size, and 100 Å pore size)
with a flow rate of 300 nl/min. The gradient started with 4% B
(80% ACN with 0.1% formic acid) and increased to 35% B over
120 min. It was followed by a washing step with 90% B for 5 min.
Mobile Phase A consisted of mQH2O with 0.1% formic acid. The
injection volume was 1 ll partial loop injection mode. For mass
spectrometric analysis, the LC was directly coupled to a high-
resolution quadrupole time of flight mass spectrometer (Triple
TOF 5600+, Sciex, USA) was used. For information-dependent data
acquisition (IDA runs), MS1 spectra were collected in the range
400–1500m/z. The 25 most intense precursors with charge state
2–4 which exceeded 100 counts per second were selected for frag-
mentation, and MS2 spectra were collected in the range 100–
1800m/z for 110 ms. The precursor ions were dynamically
excluded from reselection for 12 s. The nano-HPLC systemwas reg-
ulated by Chromeleon 8.8 (Dionex) and the MS by Analyst Software
1.7 (Sciex). Processed spectra were searched via the software Pro-
tein Pilot (Sciex) against T. gondii extracted from the UniProt_-
TREMBL database as well as against our C. suis protein database
using the following search parameters: Global modification: Cys-
teine Alkylation with Iodacetamide, Search effort: rapid, FDR anal-
ysis: Yes. Proteins with more than two matching peptides at > 95%
confidence were selected.
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3.1. Genome assembly
We generated a total of 14,776 contigs from 80 M paired-end
Illumina reads (see Supplementary Table S2 for mapping statis-
tics). The assembly had an N50 of 29,979 bp, with minimum and
maximum contig lengths of 89 bp and 285,055 bp. (N50 is the lar-
gest length L such that 50% of all nucleotides are contained in con-
tigs of a size that is at least L.) A graphical distribution of contig
lengths is shown in Fig. 1A. To exclude bacterial and other contam-
inations, we aligned the contigs to the nr database and retained
14,630 contigs without matches to other organisms outside the
Apicomplexa and covering a length of 83.6 Mb. We used this set
of contigs for the remainder of the analyses. In Table 1 we reportFig. 1. General contig-based statistics for the Cystoisospora suis genome. (A) Distribution
Toxoplasma gondii; contigs are colored according to orientation (blue = plus, red = minus)
gondii apicoplast to the two best matching C. suis contigs (different colors are used for th
figure legend, the reader is referred to the web version of this article.)
Table 1
Comparison of genome features among Cystoisospora suis and its closest relatives from th
Data for other coccidia were extracted from ToxoDB version 24 (for Sarcocystis neurona, v
Feature Eimeria tenella Sarcocystis neurona Cystoisospora s
Genome size (Mb) 51.9 128 83.6
GC content (%) 55.0 51.2 50.0a comparison about genome size and GC content between C. suis
and other coccidians.
To investigate evolutionary divergence from other coccidians
we aligned the C. suis contigs to the genomes of the closest rela-
tives, T. gondii and N. caninum, in the coccidian phylogeny
(Fig. 2). Only 27.8% and 28.1% of the C. suis bases aligned, respec-
tively, to T. gondii and N. caninum (Fig. 1B). This translated into
722 C. suis contigs successfully aligned to T. gondii, covering a total
of 3,143 C. suis genes, and 733 contigs aligned to N. caninum,
including 3,195 C. suis genes.
The GC content of the C. suis genome was 50.0%, similar to that
of other coccidian species (Table 1). Among repetitive sequences
5.07% were simple repeats, 1.84% low complexity regions and
0.02% small RNAs. We identified 93 genes associated with
transposons distributed as follows: 58 genes from the ty3-gypsyof C. suis contig lengths. (B) Alignment of C. suis contigs to the chromosomes (chr) of
. Only 27.8% of the contigs base pairs align to T. gondii. (C) BLAST alignment of the T.
e bands for graphical clarity). (For interpretation of the references to colour in this
e subclass Coccidia. Organisms are sorted according to phylogenetic position (Fig. 2).
ersion 28).
uis Neospora caninum Hammondia hammondi Toxoplasma gondii
59.1 67.7 65.7
52.8 61.0 48.5
Fig. 2. Phylogenetic tree showing the relationships among the coccidian species
analysed in this study (Toxoplasma gondii, Hammondia hammondi, Neospora
caninum, Cystoisospora suis, Sarcocystis neurona, Eimeria tenella) reconstructed using
the glyceraldehyde 3 phosphate dehydrogenase 1 (GAPDH1) gene. The T. gondii
protein TGME49_269190 was aligned with BLASTP (default parameters) to the
proteomes of the other species and the best hit was retained. Protein sequences
were aligned with PRANK (Loytynoja and Goldman, 2005) (parameters –f = phylipi
–protein) and a maximum likelihood tree was constructed using proml from the
PHYLIP package (Felsenstein, J. 2005. PHYLIP (Phylogeny Inference Package) version
3.6. Distributed by the author. Department of Genome Sciences, University of
Washington, Seattle, USA) with parameters ‘‘Speedier but rougher analysis? No, not
rough”.
194 N. Palmieri et al. / International Journal for Parasitology 47 (2017) 189–202subclass, six tf2 retrotransposons, one FOG transposon and 28
genes encoding for retrotransposon accessory proteins, such as
gag/pol.
Most apicomplexan parasites possess a special organelle called
the apicoplast (Sato, 2011), which is a plastid acquired through
secondary horizontal transfer from an algal ancestor and has func-
tions related to secondary metabolism. We attempted to identify
contigs corresponding to the apicoplast genome. By aligning the
T. gondii apicoplast sequence to the C. suis contigs using BLASTN
(default parameters), we found that 89.4% of the T. gondii sequence
mapped to three C. suis contigs. Most of the apicoplast sequence
was covered by contig 294 (24 kb) (Fig. 1C), with additional short
fragments located on contigs 1252 (Fig. 1C) and 6453 (not shown
as it contained redundant sequence overlapping with contig
1252). Gene annotation confirmed the apicoplast origin of these
contigs, with a total of 25 protein-coding genes all well conserved
with T. gondii. The genes encode for 14 ribosomal proteins, the
elongation factor tu, orf c, d, e, f, the caseinolytic protease C, four
RNA polymerases and the cysteine desulfurase activator complex
subunit. Four of the ribosomal proteins contain a premature stop
codon, which might suggest that they are pseudogenes. Finally, five
T. gondii genes did not have an ortholog in the C. suis apicoplast. To
further characterise apicoplast genes we looked at RNA-Seq
expression data from merozoites (Hehl et al., 2015), however we
found none of the genes to be expressed in either C. suis or T. gondii
at this stage. The complete list of apicoplast genes is available in
Supplementary Table S3.3.2. Genome annotation
To annotate protein-coding genes we applied the MAKER pipe-
line, as outlined in Section 2.3, followed by a manual curation ofTable 2
Comparison of annotation features among Cystoisospora suis and its closest relatives from t
Data for other coccidia were extracted from ToxoDB version 24 (for Sarcocystis neurona, v
Feature Eimeria tenella Sarcocystis neurona Cystoisospora s
Genes 8,634 7,089 11,572
Transcripts 8,634 7,089 11,572
Exons 38,606 43,976 47,706
Genes with 50UTRs 0 0 9,806
Genes with 30UTRs 0 0 8,485
a Untranslated regions (UTRs) have been annotated by Ramaprasad et al. (2015), buteach individual gene. To quantify the effect of curation we com-
puted the total number of genes, the percentage of exonic base
pairs overlapping with exons generated from the RNA-Seq dataset
(nucleotide level sensitivity – also described in Burset and Guigo
(1996)) and the percentage of genes with UTRs before and after
curation. The initial uncurated annotation contained 10,065 genes
with a nucleotide level sensitivity of 68.8%, 5,553 genes with 50
UTRs and 4,911 genes with 30 UTRs. After curation, we obtained
11,572 genes, a nucleotide level sensitivity of 85.1%, 9,806 genes
with 50 UTRs and 8,485 genes with 30 UTRs. These results showed
that our curation greatly enhanced the quality of the annotation
by increasing the concordance with transcriptional evidence and
the number of genes with UTRs.
The total gene number appears to be higher in C. suis compared
with other coccidians (Table 2), although lowly expressed genes
might represent transcriptional noise and artificially increase the
total gene count. To test this hypothesis, we removed genes with
FPKM < 1, as this threshold is commonly used to distinguish tran-
scriptional noise from real transcription. We detected 1,207 genes
(10.4%) with FPKM < 1, implying that lowly expressed genes can
only partially account for the higher number of genes in C. suis
compared with other species.
To verify the completeness of our annotation, we checked for
the presence of eukaryotic core genes that should be conserved
in all eukaryotes (Parra et al., 2007). From 458 eukaryotic core
genes, 396 (86%) were present in our gene catalogue. We looked
for the presence of the missing genes in filtered contigs and in tran-
scripts reconstructed de novo from the RNA-Seq dataset. Of the
remaining 62 eukaryotic core genes, none were found in the fil-
tered contigs and 16 were found in the de novo assembled tran-
scripts. A total of 46 eukaryotic core genes was thus not found in
our C. suis data. To shed light on whether these might constitute
missing annotations or genuine losses, we looked for their pres-
ence in the proteomes of the coccidian species listed in Table 1.
We found 29 genes present in at least one coccidian species. The
remaining 17 genes were not found in any species, and thus were
likely true gene losses in this clade (Supplementary Table S4). If
this set of genes is excluded from the initial list of eukaryotic core
genes a final completeness of (396 + 16)/(458  17) * 100 = 93% is
obtained.
To further assess the quality of the annotation we assigned to
each gene a binary vector summarizing the kind of evidence that
was used to annotate it (transcriptional, orthology-based or ab ini-
tio). Generally, the most reliable source of annotation is transcrip-
tion evidence, followed by orthology inference and ab initio
predictions. Of a total of 11,572 genes, 10,452 (90.3%) were sup-
ported by transcription evidence (Cufflinks). Among the remaining
1,120 genes, 435 (3.8%) were supported by orthology evidence
(Exonerate) and 338 (2.9%) only by ab initio predictors (either
Augustus or Snap). Finally, 347 genes (3.0%) were only partially
supported by any kind of evidence and would require further
curation.
Next, we predicted CDS for 11,545 genes (99.8%) using ORFPre-
dictor (Min et al., 2005). We classified genes according to the com-
pleteness of the CDS as follows: 7,801 genes (67.8%) had ahe subclass Coccidia. Organisms are sorted according to phylogenetic position (Fig. 2).
ersion 28).
uis Neospora caninum Hammondia hammondi Toxoplasma gondii
7,266 8,176 8,920
7,266 8,176 8,920
43,092 47,096 49,023
0a 0 5,699a
0a 0 6,128a
not yet included in ToxoDB.
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only a start codon, 1,161 (10.0%) only a stop codon and 619
(5.4%) were CDS fragments, i.e. without start and stop codons.
The complete annotation of C. suis including exons, introns, CDS
and UTRs is available at the NCBI database under accession number
PRJNA341953.
Finally, the phylogenetic distribution of C. suis genes was
assessed using OrthoMCL and found that 6,387 (55.4%) of the pro-
tein coding genes were assigned to an ortholog group.
3.3. Detection of vaccine candidates
We applied the tool Vacceed to screen the C. suis proteome for
vaccine candidates. Due to the high computation time of the MHC-I
Binding tool, the Vacceed analysis was divided into two steps (see
Section 2.7). Fig. 3A shows the score distribution after the first step
of Vacceed. This resulted in a clearly bimodal distribution from
which 2,905 proteins with a score > 0.75 were selected. During
the second step of Vacceed we refined this set including the
MHC-I Binding tool and obtained 1,168 final candidate proteins
(non-stringent set). By looking at the classification of candidates
by functional class (Fig. 3B), we observed that most of the proteins
had no annotated function (403 proteins) or contained transmem-
brane domains but had unknown function (230 proteins). Among
proteins with known function, the most abundant were channels
and transporters (147 proteins), followed by proteins involved in
metabolism and biosynthesis (118 proteins). Notable was the pres-
ence of apicomplexan-specific secretory organelles proteins (27
proteins) such as rhoptry kinases, microneme and dense granule
proteins, which are involved in parasite motility, attachment, inva-
sion and re-modelling of the intracellular parasite environment.
3.4. Contribution of immunogenic features
Next, we wanted to establish the contribution of different
immunogenic features in defining a protein as immunogenic, as
Vacceed utilises different sources of evidence from various tools:
WoLf PSORT to predict protein subcellular localisation; SignalP,
TargetP, Phobius for detecting transmembrane domains; TMHMM
and MHC-I Binding. For this analysis, we excluded MHC-I Binding
due to its high computational burden. For each tool, Vacceed was
run on the C. suis proteome using all other tools except for the tool
in question (i.e. all tools except WoLf, then all tools exceptBA
Fig. 3. General statistics for the non-stringent set of vaccine candidates. (A) Distributio
Histocompatibility Complex (MH-I) binding (see Section 2.7). (B) Functional classificatioTMHMM and so on) and the score distributions were compared
with the one computed using all tools (Fig. 4). All correlations were
very high, showing that removing any one of the tools from Vac-
ceed did not significantly affect the score distribution. However,
it appeared that TMHMM was the program that contributed most
to the immunogenic score since, when it was omitted, the correla-
tion with the score computed with all tools was the lowest
(r = 0.94).3.5. Comparison with vaccine candidates in other coccidians
Vaccine candidates in coccidians can point to homologous pro-
teins that may also induce immune protection against other coc-
cidians. For this reason, we collected all tested vaccine
candidates from an extensive screen of the published literature
(Lillehoj and Lillehoj, 2000; Jenkins, 2001; Nishikawa et al., 2002;
Bhopale, 2003; Elsheikha and Mansfield, 2004; Williams and
Trees, 2006; Dlugonska, 2008; Jongert et al., 2009; Nam, 2009;
Reichel and Ellis, 2009; Monney et al., 2011; Cui et al., 2012;
Blake and Tomley, 2014; Hiszczynska-Sawicka et al., 2014; Lim
and Othman, 2014; Monney and Hemphill, 2014) and from the
VIOLIN database (Xiang et al., 2008) for E. tenella, S. neurona, N. can-
inum and T. gondii. No previously tested candidates were found for
H. hammondi. We found 13 candidates for E. tenella, one for S. neu-
rona, 19 for N. caninum and 43 for T. gondii, giving a union set of 58
total candidates (Fig. 5). These mostly included apicomplexan-
specific secretory organelle proteins and surface antigens, which
are known to be directly involved in the invasion process, but also
a heterogeneous set of other proteins with no overrepresented
function. Out of the 58 candidates, 34 were also present in the C.
suis proteome and seven overlapped with our set of C. suis vaccine
candidates, namely proteins orthologous to microneme proteins
TgMIC8 and TgMIC13, the dense granule antigen TgGRA1, the sur-
face antigen TgSAG1, the cyclophilin CyP, the immune mapped
protein IMP1 and the protein disulphide isomerase PDI. This
enrichment of previously described vaccine candidates in our Vac-
ceed set was highly significant (one-tailed Fisher’s Exact Test –
P = 2.2  105). Notably, most previously described rhoptry and
dense granule candidate vaccine proteins were absent in C. suis,
as they originated before the split of T. gondii, H. hammondi and
N. caninum. On the other hand, many microneme proteins were
present in C. suis but they were not classified as vaccine candidates
in our study: three of those (orthologues of TgMIC2, TgMIC5,n of Vacceed scores for Cystoisospora suis proteins using all the tools except Major
n of vaccine candidates.
Fig. 4. Correlation plot of Vacceed score distributions computed with different combinations of predictors. Each square contains the Pearson correlation coefficient between
two Vacceed runs on all the C. suis proteins. (All predictors = Vacceed run using all predictors; NO WoLf = Vacceed run using all predictors except WoLf; other labels are
similarly constructed).
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our threshold, while the remaining three (TgMIC1, TgMIC3,
TgMIC4) had a very low score.
3.6. Evolutionary conservation of vaccine candidates
Proteins that are phylogenetically restricted to C. suis or con-
served only among closely related species might be more attractive
candidates for experimental testing, since proteins with homologs
and conserved epitopes in the host might induce an unwanted
autoimmune response. To study the evolutionary conservation of
vaccine candidates, we applied OrthoMCL and classified proteins
according to taxonomic levels (Fig. 6). Approximately 28% of the
proteins were very conserved in eukaryotes or shared by all organ-
isms (set V1), another 29% were restricted to coccidians, apicom-
plexans or alveolates (set V2), while the largest fraction (43%)
was not assigned to any ortholog group (set V3). If one would
exclude the most conserved proteins (set V1) from in vitro testing,
there is still a large set of candidates (839 proteins) to be investi-
gated. By looking at GO functional enrichment of apicomplexan-
specific and coccidian-specific proteins we observed a significant
overrepresentation for ‘‘calcium ion binding” (P < 2.5  107) and
‘‘protein kinase activity” (P = 0.00067). Similarly, for coccidian-
specific proteins the most prominent functional terms were ‘‘cal-
cium ion binding” (P < 7.4  106) and ‘‘cyclic-nucleotide phospho-
diesterase activity” (P = 0.00015).
3.7. Expression of vaccine candidates in merozoites
It is usually assumed that highly expressed genes are more
likely to induce a sustained immunogenic response compared with
lowly expressed ones (Flower et al., 2010; Goodswen et al., 2014a).
To gain insight into the expression of genes encoding for immuno-
genic proteins we performed an RNA-Seq experiment usingpolyadenylated RNA purified from C. suismerozoites, as those con-
stitute the primary intracellular reproductive stage of C. suis and
interact directly with the host during invasion. Genes with func-
tions related to invasion were the most highly expressed (Fig. 7A)
and included surface antigens, apicomplexan-specific secretory
organelles, cell adhesion and motility, and parasitophorous
vacuole-related genes. When looking at the total ranked set of can-
didates according to expression level (Fig. 7B), we observed that
more than 50% of the highly expressed candidates had unknown
functions. Other proteins such as transporter abcg89, cytochrome
b and c, were highly expressed and well characterised, but phylo-
genetically highly conserved and thus less suitable for further
experimentation. Finally, 13 uncharacterised genes (unknown
function or including generic transmembrane domains) with very
high expression (FPKM > 30) and C. suis specificity might constitute
attractive candidates for in vitro testing (Fig. 7B – proteins anno-
tated as ‘‘–NA–‘‘ or ‘‘transmembrane protein”).
3.8. Stringent list of vaccine candidates
To produce a more stringent list of candidates, we selected from
the 1,168 vaccine candidates only those proteins that were highly
expressed in merozoites (FPKM > 30, which corresponds to the top
25% of the expression distribution of vaccine candidates, see
Fig. 7A – category ‘‘All”) and without orthologs outside the Api-
complexa. This resulted in a set of 220 proteins. These include
152 proteins with unknown function, of which 88 contain trans-
membrane domains. Additionally, there were 17 surface antigens
related to the TgSAG/SRS gene families, 12 apicomplexan-specific
secretory organelles proteins including orthologues of TgAMA1,
TgMIC6, TgMIC13, TgROP6, TgROP12, TgROP27, TgROP32, nine pro-
teins involved in metabolism and biosynthesis, seven channels and
transporters proteins and three proteins related to cell adhesion.
For the complete list of candidates see Supplementary Table S5.
Fig. 5. Orthology comparison of vaccine candidate proteins between Cystoisospora suis and other coccidian spp. Hammondia hammondi was excluded as no vaccination
studies have been performed. Orthologs of C. suis genes were detected using the Orthology Matrix (Altenhoff et al., 2013) (see Section 2.8).
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To test whether vaccine candidate proteins interact with the
host immune system and induce an immune response during C.
suis infection, we performed a 2D immunoblot experiment using
positive polyclonal sera from experimentally infected piglets. We
resolved crude lysates from cultured C. suis merozoites using a
broad range (pH 3–10) of 2D gels. These revealed 18 spots that
were easily visualised by silver staining, likely corresponding to
the most highly expressed proteins in the merozoite proteome
(Fig. 8A). To detect proteins that are recognised as antigenic by
serum antibodies of infected hosts, we performed an immunoblot
of the 2D gel probed with highly positive sera from experimentallyinfected piglets. This revealed one immuno-reactive spot (Fig. 8B),
whereas no reactive spots were detected in the immunoblot
probed with precolostral sera (data not shown). Protein sequencing
by mass spectrometry showed that the spot corresponded to a set
of eight proteins (Table 3). Remarkably, one of these proteins over-
lapped with our set of vaccine candidates (CSUI_005805). This pro-
tein had no annotated function, but showed a very high expression
level (FPKM = 10,244) (Fig. 7B) and was C. suis-specific, according
the OrthoMCL orthology assignment, making it a very attractive
vaccine candidate. The protein was predicted to be short (389
amino acids), with a molecular weight of 42 kDa and encoded by
a single-exon gene located on contig 2816. To further characterise
this protein we analysed its sequence using Phobius (Kall et al.,
Fig. 6. Phylogenetic distribution of the non-stringent set of vaccine candidates.
Each circle contains the number of genes shared by that taxonomical group. See the
Section 3.6 for the descriptions of the different sets (V1, V2 and V3).
A
Fig. 7. Gene expression statistics for the non-stringent set of vaccine candidates (A) Mero
(B) Gene expression of the top 20 most expressed vaccine candidates. FPKM, Fragments
Fig. 8. Protein blots of Cystoisospora suis merozoites lysates (A) Two-dimensional proteo
detectable proteins; the circle marks the spots identified by western blot (B). (B) Two-dim
from infected piglets. NL, non-linear.
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by a short cytoplasmic region and followed by a longer extracellu-
lar tail (Fig. 9A). Screening of this protein with the B-cell epitope
predictor from the IEDB Analysis Resource tools (Larsen et al.,
2006) revealed the presence of several putative epitopes along
the sequence (Fig. 9B). No additional information about the func-
tion of CSUI_005805 was currently available, as this protein lacks
orthologs in other organisms. By virtue of all its features such as
a high Vacceed score, high expression, species specificity and
in vitro immunoreactivity, we conclude that the CSUI_005805 pro-
tein constitutes an attractive vaccine candidate for further experi-
mental testing.4. Discussion
In this study, we sequenced, assembled and annotated the gen-
ome of C. suis, an apicomplexan species of worldwide veterinary
relevance. We used this new resource to predict a panel of putative
vaccine candidate proteins, which hopefully will serve to develop a
novel subunit vaccine. We performed this analysis by combining in
silico predictors of protein immunogenicity with transcription and
comparative genomics data.B
zoite expression distribution of vaccine candidates classified by functional category.
per Kilobase of Exon per Million reads.
me map of C. suis merozoite lysates visualised using silver stain; arrows mark the
ensional immunoblot profile of C. suismerozoite lysates detected using positive sera
Fig. 9. Structural information for the vaccine candidate protein CSUI_005805. (A) Domain prediction performed with the program Phobius on the protein CSUI_005805.
Different colors indicate the regions of the protein in relationship to the cell membrane. The drawing in the red-bordered rectangle depicts a simplified representation of the
protein structure. (B) B-cell epitope prediction performed with the Immune Epitope Database (IEDB) Analysis Resource tools on the protein CSUI_005805. The yellow peaks
indicate the locations of the epitopes. For an explanation of the scoring system see Larsen et al. (2006). (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)
Table 3
Proteins identified in the immunoblot experiment with pig serum. Vaccine candidates are highlighted in gray.
FPKM, fragments per kilobase of exon per million reads.
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other coccidian species identified a relatively large assembly for
C. suis, with only S. neurona found to be bigger. To understand
whether this discrepancy was due to expansion of intergenic
regions within the C. suis genome, we compared the length of genic
and intergenic regions in C. suis and T. gondii and found no signif-
icant difference in proportions between the two species (C. suis
intergenic = 26.3 Mb, genic = 57.4 Mb; T. gondii inter-
genic = 16.5 Mb, genic = 49.2 Mb; Fisher’s Exact Test P = 0.4629).
Similarly, the proportions of exon to intron lengths were also not
significantly different between the two species (C. suis
exons = 34.6 Mb, introns = 23.5 Mb; T. gondii exons = 29.7 Mb,
introns = 19.9 Mb; Fisher’s Exact Test P = 1). Finally, repetitive
regions were also not responsible for the difference in genome size
(C. suis repetitive = 5.8 Mb, C. suis non-repetitive = 77.8 Mb, T. gon-
dii repetitive = 2.6 Mb, T. gondii non-repetitive = 63.1 Mb; Fisher’s
Exact Test P = 0.5371). However, we caution that different genome
assembly technologies and annotation strategies for different spe-
cies might bias the comparison of genomic features among assem-
blies. Features such as average GC content were also consistent
with those reported for other coccidians (Kissinger and DeBarry,
2011). Alignment of the C. suis contigs to assemblies representing
the closest coccidian relatives showed that less than 30% of the C.
suis assembly could be aligned to T. gondii or N. caninum. It has pre-
viously been shown that 90% of the N. caninum contig base pairs
could be aligned to the T. gondii assembly, indicating a greater evo-
lutionary divergence between C. suis and T. gondii. The next step
will be to estimate the evolutionary divergence in millions of years
between C. suis and its sister species.
Our annotation of the predicted C. suis transcriptome suggests
more than 11,000 genes, considerably higher than most other coc-cidians, but consistent with the larger genome size. We evaluated
the quality of our annotation using a range of metrics and found
86% of the core eukaryotic genes to be present. Notably, if we
exclude core eukaryotic genes that are absent in the whole coccid-
ian clade, thus also expected to be absent in C. suis, this proportion
rises to 93%. Expression data validated 90% of the gene models,
pointing to a high degree of completeness and reliability of the
gene structures. Additionally, we performed a gene-by-gene man-
ual curation, which greatly enhanced the quality of the annotation,
by increasing the concordance with transcriptional evidence by
almost 20% and the number of genes with UTRs by 30%. The lar-
ger number of genes predicted compared with most other coccid-
ians might be a consequence of more orphan genes (Martens et al.,
2008), supported by the fact that more than 40% of the C. suis genes
could not be assigned to any orthologous group. Alternatively, frag-
mented gene models might have resulted in an overestimation of
gene number. However, gene numbers in other coccidians might
also have been underestimated since most recent RNA-Seq based
annotations (Ramaprasad et al., 2015) have not yet been incorpo-
rated into ToxoDB. In our annotation, most of the genes identified
(99%) had coding potential. While non-coding RNAs were not
explicitly annotated, it is likely that polyadenylated non-coding
RNA (Matrajt, 2010), such as long non-coding RNAs (lincRNAs),
constitute a minor fraction of the gene catalogue of C. suis, as also
previously shown for T. gondii (Hassan et al., 2012).
Another feature specific to the apicomplexan clade is the pres-
ence of the apicoplast organelle in most of its members, except the
gregarine-like Cryptosporidium (Zhu et al., 2000). Two contigs were
found to contain most the C. suis apicoplast genome, confirming
the presence of this organelle in this species. Comparison with T.
gondii revealed a high level of conservation for the C. suis apicoplast
200 N. Palmieri et al. / International Journal for Parasitology 47 (2017) 189–202genes, although some genes contained premature stop codons,
implying a recent pseudogenisation event. This phenomenon has
also been described in T. gondii (Sato, 2011), where it was sug-
gested that internal stop codons might be interpreted as trypto-
phan coding by the translation machinery. The absence of
transcripts derived from these genes within the RNA-Seq data pre-
clude confirmation for C. suis since transcription may simply have
been low in the single merozoite lifecycle stage sampled. Consis-
tent with these results, T. gondii orthologs of C. suis apicoplast
genes also had very low expression levels in 3 days p.i. merozoites
according to the expression data from the ToxoDB database (Hehl
et al., 2015) (Supplementary Table S3).
Screening the predicted C. suis proteome, 1,169 putative vaccine
candidates were identified using the software Vacceed. We further
characterised the candidates according to function, conservation,
expression and overlap with candidates that had been tested in
other coccidians. Most of the candidates were annotated as of
unknown function and remarkably many had no orthologs in other
coccidian species. Such diversity might be due to accelerated evo-
lution of proteins that interact with the immune system of the
host, as formerly reported for other apicomplexan species
(Templeton et al., 2004; Jackson et al., 2014; Blake et al., 2015).
Vaccine candidate proteins involved in host interaction and inva-
sion such as apicomplexan-specific secretory organelles proteins,
surface antigens and cell adhesion proteins were highly expressed
in merozoites, as might have been expected given their function in
the C. suis lifecycle. Interestingly, when vaccine candidates identi-
fied in other coccidian species were compared, only 22% of the can-
didates with orthologs in C. suis had a high Vacceed score. To
understand why some known candidates had a low score in C. suis
we looked at the partial scores from the various tools that consti-
tute the Vacceed pipeline. Many proteins had very low partial
scores, indicating the absence of specific signals for membrane,
secretion or MHC1-binding epitopes. Additionally, when we looked
at protein domains from the InterPro database we did not find any
domain related to membrane, secretion or interaction with the
immune system (data not shown). This indicates that membrane-
related signals might not always be required features for an antic-
occidial vaccine candidate. A relatively high proportion (43%) of
candidates identified in other coccidians had no orthologs in C. suis.
By looking at the phylogenetic patterns of these proteins, these
candidates were found to be either specific to E. tenella (gam56,
gam82, GX3262, GX3264, MA16) or they were proteins that origi-
nated just before the split of N. caninum, H. hammondi and T. gondii,
mostly rhoptry kinases, dense granules and some surface antigens
of the SRS family. These results also reflect the likely fast evolution
of immune-related proteins. Finally, by overlapping the vaccine
candidates obtained by Vacceed with proteins identified from an
immunoblot experiment of pig serum, we pinpointed a promising
new vaccine candidate corresponding to a 42 kDa transmembrane
protein with unknown function (CSUI_005805). However, only a
few proteins were recognised by positive sera from infected pig-
lets. More sensitive detection methods or increased amounts of
proteins on the gel would certainly reveal more positive spots.
To further confirm the usefulness of candidates identified by
reverse vaccinology and immunoblotting, recombinant proteins
must be generated and characterised in vitro and in vivo in further
experiments
In summary, we combined reverse vaccinology with transcrip-
tomics and comparative genomics to identify a list of vaccine can-
didate proteins for further experimental testing. In order to restrict
this set of candidates, new indicators of immunogenicity could be
incorporated into the Vacceed pipeline, which is feasible due to the
modularity of this tool. Studies on putatively immunogenic pro-
teins of C. suis will also greatly enhance our understanding of the
immune mechanisms underlying protection (or immunopathol-ogy) in porcine cystoisosporosis. Lastly, the genome and annota-
tion of C. suis constitute a new step in the genomic era of
apicomplexans. As the genus Cystoisospora can also be found in
other hosts such as dogs, cats and humans, we anticipate that these
resources will help to unravel the evolutionary mechanisms of host
specificity in apicomplexan parasites.
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